Upstream Bio is a biotech company that strives to reach the source of inflammation and conquer it. The company's lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor which is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases, allowing medical professionals to ease the burden of inflammatory and allergic...
Upstream Bio is a biotech company that strives to reach the source of inflammation and conquer it. The company's lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor which is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases, allowing medical professionals to ease the burden of inflammatory and allergic diseases with novel therapeutics on patients.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.